摘要
目的:通过对上海市金山区某小学学生屈光发育情况进行调查,分析新冠疫情前后该校小学生近视的流行病学特点。方法:2018—2021年连续4年随机抽取上海市金山区某小学1~5年级学生(7~11岁)作为研究对象,进行屈光检查,其中2018—2019年为疫情前,2020—2021年为疫情后。采用非散瞳电脑验光并记录等效球镜(SE),比较不同年份、不同年龄学生近视患病率及右眼SE情况。结果:2018—2021年调查对象近视总患病率分别为44.33%、38.44%、52.70%和51.41%,差异有统计学意义(χ^(2)=57.15,P<0.01)。与疫情前相比,疫情后除8岁组学生外,7岁、9岁、10岁、11岁年龄组学生右眼SE情况比较,差异均有统计学意义(F值分别为7.41、7.15、3.90和4.05,P值均<0.05)。与疫情前相比,疫情后7岁组男、女生右眼SE均明显下降;9~11岁男生右眼SE明显下降,而女生右眼SE无明显变化。结论:疫情后金山区某小学学生近视患病率较疫情前有所增加,7岁男女生及9~11岁男生近视情况更为严重,应更加重视学龄前儿童及9~11岁男生的近视防控工作。
OBJECTIVE To investigate the refractive development of primary school students in Jinshan District of Shanghai,and to analyze the epidemiological characteristics of myopia in primary school students before and after the COVID-19 epidemic.METHODS In a cross-sectional study,students from grades 1 to grade 5(7 to 11 years old)in Jinshan District of Shanghai were randomly selected for four consecutive years from 2018 to 2021,with 5 classes in each grade,of which was before the epidemic.The prevalence of myopia and SE in the right eye in different years.RESULTS The total prevalence of myopia in 2018-2021 was 44.33%,38.44%,52.70%and 51.41%,respectively,statistically significant(χ^(2)=57.15,P<0.01).Before and after the outbreak,except for the 7,9,10 and 11 years old age group(F=7.41,7.15,3.90,4.05,P<0.05).Compared with before the outbreak,the SE in the right eye in the right eye of boys aged from 9 to 11 years,but the SE in the right eye.CONCLUSION The prevalence of myopia in primary school students in Jinshan District increased after the epidemic,and the development of myopia was more serious in boys and girls aged 7 years and boys aged 9~11 years.More attention should be paid to the prevention and control of myopia in preschool children and boys aged 9~11 years.
作者
罗芳
李涛
戚慧荭
陈雪峰
LUO Fang;LI Tao;QI Hui-hong;CHEN Xue-feng(Deartment of Ophthalmology,Jinshan Hospital of F udan Univesity,Shanghai,201508,China;不详)
出处
《中国初级卫生保健》
2023年第5期76-79,共4页
Chinese Primary Health Care
关键词
小学生
近视
患病率
流行病学
新冠疫情
primary school students
myopia
prevalence
epidemiology
COVID-19
